Related Experiment Videos
Gastroenterology and hepatology clinical research update: 2005-2006
1Mayo Clinic College of Medicine, Clinical Neuroscience Translational and Epidemiological Research Program, Rochester, MN 55905, USA. camillieri.michael@mayo.edu
Insights
This review covers recent gastroenterology and hepatology research, including pediatric eosinophilic esophagitis, Barrett's esophagus screening, and celiac disease management. It also addresses inflammatory bowel disease, colorectal cancer, and new treatments for constipation and obesity.
Area of Science:
- Gastroenterology and Hepatology clinical research.
Background:
- Highlights research published in Clinical Gastroenterology and Hepatology over the past year.
- Summarizes key findings presented at the American Gastroenterological Association Presidential Plenary Session in May 2006.
Purpose of the Study:
- To review significant advancements and emerging trends in clinical gastroenterology and hepatology.
- To provide an overview of research topics relevant to the field.
Main Methods:
- Literature review of predominantly Clinical Gastroenterology and Hepatology publications.
- Synthesis of research presented at a major gastroenterological conference.
Main Results:
- Covers diverse topics: eosinophilic esophagitis, Barrett's esophagus dysplasia/carcinoma detection, celiac disease management (elemental diet, gluten predigestion).
- Discusses NSAID safety in inflammatory bowel disease, steroid effects on abscesses, and colorectal cancer prognosis in IBD.
- Examines familial colorectal cancer screening, a new familial colorectal cancer syndrome, and treatments for constipation and obesity.
- Addresses hepatoma risk factors in underserved groups and novel imaging/biological diagnostic applications.
Conclusions:
- The review synthesizes a broad spectrum of critical updates in gastroenterology and hepatology.
- It underscores the dynamic nature of research in diagnosing and managing gastrointestinal and liver disorders.
Abstract:
This review highlights areas of clinical research in gastroenterology and hepatology that were published predominantly in the journal Clinical Gastroenterology and Hepatology during the last year and were summarized during the American Gastroenterological Association Presidential Plenary Session in May 2006. The topics included eosinophilic esophagitis in children, detecting high-grade dysplasia or carcinoma in Barrett's esophagus, advances in management of celiac disease with elemental diet or gluten predigestion, the safety of NSAIDs in inflammatory bowel disease, the role of steroids in development of abscesses, prognosis of colorectal cancer associated with inflammatory bowel disease, screening for familial colorectal cancer in apparently sporadic disease, a new syndrome of familial colorectal cancer, new drugs in the treatment of chronic constipation and obesity, hepatoma risk factors and underserved racial/ethnic groups, and the application of new imaging and biology in diagnosis of gastroenterological disorders.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acute Pancreatitis II: Clinical Manifestations and Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test